1.Curtis A. Clark, Lauren K. Thomas, and Ali O. Azghani.
2011. Inhibition of PKC attenuates Pseudomonas aeruginosa
elastase-induced epithelial barrier disruption. Am. J. Respir. Cell Mol.
14 July 2011.
2. Azghani, Ali. 2010. The Central Dogma of Molecular Biology and the New Clinical Research Order. The Monitor, 24(1); 25-28.
3. Alipour M, Suntres ZE, Halwani M, Azghani AO,
Omri A. 2009. Activity and interactions of liposomal antibiotics in
presence of polyanions and sputum of patients with cystic fibrosis. PLoS
One, 4(5):e5724.
4. Halwani M, Hebert S, Suntres ZE, Lafrenie RM, Azghani AO,
Omri A. 2009. Bismuth-thiol incorporation enhances biological
activities of liposomal tobramycin against bacterial biofilm and quorum
sensing molecules production by Pseudomonas aeruginosa. Int J Pharm.
2009 May 21;373(1-2):141-6.
5. Halwani, M, B. Yebio1, Z. E. Suntres, M. Alipour, A. O. Azghani, and A. Omri1, 2008.
Co-encapsulation of gallium with gentamicin in liposomes enhances
antimicrobial activity of gentamicin against Pseudomonas aeruginosa.
Journal of Antimicrobial Chemotherapy 62(6):1291-7, 2008.
6. Halwani, M, Shanna Blomme , Zacharias E. Suntres, Misagh Alipour, Ali O. Azghani,
Aseem Kumar, Abdelwahab Omri. 2008. Liposomal Bismuth-Ethanedithiol
Formulation Enhances Antimicrobial Activity of Tobramycin. International
Journal of Pharmaceutics, 2008, 358(1-2): 254-63, 2008.
7. Idell S, Azghani A,
Chen S, Koenig K, Mazar A, Kodandapani L, Bdeir K, Cines D,
Kulikovskaya I, Allen T. 2007. Intrapleural low-molecular-weight
urokinase or tissue plasminogen activator versus single-chain urokinase
in tetracycline-induced pleural loculation in rabbits. Exp Lung Res.
33(8):419-40, 2007.
8. Yarlagadda, B, N. Subramanian, and A. Azghani,
2007. Artificial Neural Network-Based Estimation for Pseudomonas
aeruginosa Experiments. IEEE Proceedings, 1-4244, 133- 137. 2007
9. Alipour Mr, Zacharias E. Suntres, Aseem Kumar, Marina Ulinova,
Ali O. Azghani and Abdelwahab Omri. 2007. Antimicrobial Properties of Liposomal Aminoglycosides. Journal of Antimicrobial Chemotherapy.
10. Steven Idell, Timothy Allen, Shande Chen, Kathy Koenig, Andrew Mazar and Ali Azghani.
2006. Intrapleural activation, processing, efficacy, and duration of
protection of single-chain urokinase in evolving tetracycline-induced
pleural injury in rabbits. Am J Physiol Lung Cell Mol Physiol.
292:25-32, 2007.
11. Majed Halwani, Clement Mugabe, Ali O. Azghani,
Robert M. Lafrenie, Aseem Kumar and Abdelwahab Omri 2007. Bactericidal
Efficacy of Liposomal-Aminoglycosides against Burkholderia cepacia. J
Antimicrob Chemother. 60(4):760-9.10 | A z g h a n i
12. Mugabe C, Azghani AO,
Omri A., 2007. Preparation and characterization of dehydration-
rehydration vesicles loaded with aminoglycoside and macrolide
antibiotics. Journal of Antimicrobial Chemotherapy, 60(4):760-9. 2007.
13. Morrow, D.M,, Tahereh Entezari-Zaher, John Romashko II, Ali O. Azghani,
Mohammad Javdan, Luis Ulloa, Edmund J. Miller, and Lin L. Mantell.
2007. Antioxidants preserve macrophage phagocytosis of Pseudomonas
aeruginosa during hyperoxia . Free Radical Biology and Medicine 42 (9),
2007.
14. Mugabe, M. Halwani, A. O. Azghani,
R. M. Lafrenie, A. Omri. 2006. Mechanism of Enhanced Activity of
Liposome-Entrapped Aminoglycosides against Resistant Strains of
Pseudomonas aeruginosa. Antimicrobial Agents and Chemotherapy. 6; 50:
2016-2022
15. Sachar, P., N. Subramanian, and
A. Azghani,
2006. A Knowledge Base for Biological Experiments. Proceedings of the
IEEE Sixth Annual Emerging Information Technology Conference, Dallas,
TX.
16. Gavin Rukholm, Clement Mugabe, Ali O. Azghani, and Abdelwahab Omri. 2006.
Antibacterial activity of liposomal gentamicin against Pseudomonas
aeruginosa : a time–kill study. International Journal of Antimicrobial
Agents 27: 247–252
17. Clement Mugabe, Ali O. Azghani,
Abdelwahab Omri. 2006. Preparation and Characterization of
Dehydration-Rehydration Vesicles Loaded Aminoglycoside and Macrolide
Antibiotics. Int. Journal of Pharmaceutics, 307: 244–250
18. Clement Mugabe, Ali O. Azghani,
and Abdelwahab Omri, 2005. Liposome-Mediated Gentamicin Delivery:
Development and Activity against Resistant Strains of Pseudomonas
aeruginosa Isolated from Cystic Fibrosis Patients. Journal of
Antimicrobial Chemotherapy, 55, 269-271.
19. Shawn Rossi, Ali O. Azghani
and Abdelwahab Omri, 2004. Antimicrobial efficacy of a new
antibiotic-loaded poly (hydroxybutyric-co-hydroxyvalaric acid)
controlled release system. Journal of Antimicrobial Chemotherapy, 54,
1013-1018.
20. Ashraf I. Zahra, Ali O. Azghani,
Jason W. Baker, Siegfried Pueblitz, Anna Kurdowska, and Steven Idell.
2004. Experimental Acute Pseudomonas aeruginosa Pneumonia in Rabbits.
The Medical Journal of Teaching Hospitals & Institutes, Egypt, 2004,
61, 49-60.
21.
Azghani, A.O.
and Rodolfo Amaro. 2003. Molecular basis of Pseudomonas inflammation
and newtherapeutic interventions in cystic fibrosis. Recent Res. Devel.
Infection & Immunity 1:387-403.
22. Azghani, A.O.,
Steven Idell, Manjeet Bains, and Robert E.W. Hancock. 2002. Pseudomonas
aeruginosa outer membrane protein F is an adhesin in bacterial binding
to lung epithelial cells in culture. Microbial Pathogenesis 33:109-14.
23. Azghani, A.O.,
Jason W. Baker, Sreerama Shetty, Ed J. Miller, and G. Jayarama Bhat.
2002. Pseudomonas aeruginosa elastase stimulates ERK signaling pathway
and enhances IL-8 production by alveolar epithelial cells in culture.
Inflammation Research 51 (10): 506 – 510.
24. Shetty, Sreerama, Usha R. Pendurthi, Prathap K. Shetty Halady, Ali O. Azghani,
and Steven Idell. Urokinase induces its own expression in Beas2B lung
epithelial cells. 2002. Am. J. Physiology, Lung Cellular and Molecular
Physiology; 283:L319-L328.
25.
Steven Idell M.D., Ph.D., Andrew Mazar Ph.D, Douglas Cines M.D., Graham
Parry Ph.D., Susan Gawlak , Jose Juarez M.S. , Kathy Koenig, Ali Azghani Ph.D.,
Will Hadden D.V.M., Jerry McLarty Ph.D. and Edmund Miller Ph.D. 2002.
Intrapleural Single-chain Urokinase Alone or Complexed to its Soluble
Receptor Protects Against Pleural Adhesions in Tetracycline-induced
Pleuritis in Rabbits. Am J Respir Crit Care Med 166: 920–926
26. Azghani, A.O.,
Miller E.J., and Peterson, B.T. 2000. Virulence factors from
Pseudomonas aeruginosa increase lung epithelial permeability. Lung, 178:
261-269.
11 | A z g h a n i
27. Azghani, A.O.
and T.F. Bedinghaus, T.F. and Klein, R. 2000. Detection of Elastase
from Pseudomonas aeruginosa in Sputum and its potential Role in
Epithelial Permeability. Lung, 178:181-189.
28. Obiso, Jr., R.J., Azghani, A.O.,
and Wilkins, T.D. 1997. Bacteriodes fragilis Disrupts the tight
junctions of epithelial cells lines. Infection & Immunity.
65:1431-1439.
29. Azghani, A.O.
1996. Pseudomonas aeruginosa and epithelial permeability: role of
virulence factors, elastase and exotoxin A. Am. J. Res. Cell & Ml.
Biol. 15:132-140.
30. Azghani, A.O.,
Williams , I.F., Holiday, D.B., and Johnson, A. R., 1995. A beta-linked
mannan inhibits adherence of Pseudomonas aeruginosa to human lung
epithelial cells. Glycobiology, 5:39-44.
31. Azghani, A.O.,
Gray, L.T., and Johnson, A.R., 1993. Bacterial Protease perturbs
paracellular barrier functions of transporting epithelium monolayers in
culture. Infection & Immunity. 61: 2681- 2686.
32.
Azghani, A.O.,
Kondepudi, A.Y., and Johnson, A.R. 1992. Interaction of Pseudomonas
aeruginosa with human lung fibroblasts: role of bacterial elastase. Am.
J. Respir. Cell and Mol. Biol. 6: 652-657.
33. Peterson, B.T., Collins, M.L., Gray, L.D., and Azghani, A.O., 1992. Aerosolized Pseudomonas elastase and lung fluid balance in anesthetized sheep. J. Appl. Physiology 72: 1927-1933.
34. Azghani, A.O.,
Connelly, J.C., Peterson, B. T., Gray, L.D., Collins, M.L., and
Johnson, A.R., 1990. Effects of Pseudomonas aeruginosa elastase on
alveolar epithelial permeability in guinea pigs. Infection &
Immunity. 58: 433-438.
35. Garcia, Joe G.N., Azghani, A.O., Callahan, K.S., and Johnson,
A.R. 1988. Effects of platelet activating factor on
leukocyte-endothelial cell interactions. Thromb. Res. 51: 83- 96.
36. Azghani, A.O.
and Fuerst, R., 1988. Studies of antibiotic resistant mutants of
Bacteroides fragilis obtained by Cs-137 ionizing radiation. J. Ind.
Microbiol. 3: 299-304.
37.
Azghani, A.O. and
Fuerst, R., 1982. Effects of gamma irradiation on Pseudomonas
aeruginosa antibiotic susceptibility. Dev. Ind. Microbiol. 123: 579-585.
BOOK CHAPTERS
1. Azghani, A.O. and Curtis Clark. 2011. Bacterial Infection Process: An overview. Infection and Immunity.
2. Alipour M, Zacharias E. Suntres, Ali O. Azghani,
and Abdlewahab Omri. 2008. Pulmonary infection in Cystic Fibrosis: Role
of quorum-sensing. Recent Development in Signal Transduction Research,
2008, Editors; CV Ramana, Richard I. Enelow and Aseem Kumar.
3. Omri, M.L Anderson, C. Mugabe, Z. Suntres, M. R. Mozafari, and A. Azghani.
2007. Artificial implants–new developments and associated problems in
nanomaterials and nanosystems for biomedical applications, Springer,
2007, Volume editor: M.Reza Mozafari
4. Azghani, A.O.
and Rodolfo Amaro. 2003. Molecular basis of Pseudomonas inflammation
and new therapeutic interventions in cystic fibrosis. Infection &
Immunity 1:387- 403; Transworld Research Network.
5. Hector, J., Azghani, A.O.,
and Johnson, A.R. 1993. Genetic regulations of elastase in P.
aeruginosa, pp. 145-162. In “Microbial Pathogenesis and Immunity,”
edited by M. Campa et al, Plenum Press, New York.